Allie Ivy
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: University of North Carolina at Chapel Hill (2024); North Carolina State University (2024)
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Allie Ivy's research focuses on developing and evaluating gene delivery methods for therapeutic applications. Her work includes the investigation of CRISPR-Cas9 delivery systems for Duchenne muscular dystrophy and the creation of dual-fluorescence assays designed to screen gene delivery vehicles in macrophages, particularly in the context of inflammation-inducible reporter constructs. Ivy has authored three publications, with her work accumulating 14 citations and an h-index of 1. She has collaborated with researchers including Christopher E. Nelson, Shilpi Agrawal, Shelby N. Bess, and Timothy J. Muldoon at the University of Arkansas at Fayetteville.
Metrics
- h-index: 1
- Publications: 3
- Citations: 15
Selected Publications
-
A dual-fluorescence assay for gene delivery vehicle screening in macrophages with an inflammation-inducible reporter construct (2025)
-
Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy (2023)
Collaboration Network
Top Collaborators
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- A dual-fluorescence assay for gene delivery vehicle screening in macrophages with an inflammation-inducible reporter construct
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- A dual-fluorescence assay for gene delivery vehicle screening in macrophages with an inflammation-inducible reporter construct
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
- A dual-fluorescence assay for gene delivery vehicle screening in macrophages with an inflammation-inducible reporter construct
- A dual-fluorescence assay for gene delivery vehicle screening in macrophages with an inflammation-inducible reporter construct
- A dual-fluorescence assay for gene delivery vehicle screening in macrophages with an inflammation-inducible reporter construct
- A dual-fluorescence assay for gene delivery vehicle screening in macrophages with an inflammation-inducible reporter construct
Similar Researchers
Based on overlapping research topics